Add Yahoo as a preferred source to see more of our stories on Google. ASHLAND A very rare genetic disease is taking its toll on a local family. Amanda Liles lives in Lewis County and worked in Ashland ...

Brief Title A National Registry for People With All Stages of Kidney Disease: the National Kidney Foundation (NKF) Patient Network The Network is a longitudinal observational cohort study that ...

Add Yahoo as a preferred source to see more of our stories on Google. LEXINGTON, Ky. (FOX 56) — Imagine learning your child needs a kidney transplant to survive. Now, imagine your other child needs ...

BAY 3401016 is an investigational monoclonal antibody with potential to block a protein called Semaphorin 3A (Sema3A), which is thought to be involved in the progression of kidney damage in Alport ...

Cory LaCasse, a musician, was diagnosed with Alport syndrome six years ago after being diagnosed with diabetes. He has lost some of his hearing and eyesight as a result. "I'm a musician so the hearing ...

Investigators reported an upward trend in the prevalence of diagnosed polycystic kidney disease, Alport syndrome, lupus nephritis, and focal segmental glomerulosclerosis from 2016 to 2020 and ...

Alport syndrome is a rare, genetic form of CKD caused by mutations in the genes encoding type IV collagen, which is a major structural component of the glomerular basement membrane in the kidney.

Kobe University ISHIMORI Shingo and his team found that the most common reason why patients were referred to hospital for testing for Alport syndrome was due to age-3 urine screening results. In ...

The Company will initiate a Phase 2 clinical study of Vonafexor in Alport Syndrome - called “ALPESTRIA-1” - in the first half of 2024. Series C proceeds will fund the Phase 2 study, as well as ...

BERLIN--(BUSINESS WIRE)-- Bayer announced today initiation of a Phase IIa clinical trial with BAY 3401016, an investigational monoclonal antibody with potential to block a protein called Semaphorin 3A ...

The most common first diagnosis of Alport syndrome in Japan is during the universal age-3 urine screening. In 60% of these children, the disease had already progressed far enough to qualify for ...